Claus Larsen

Title: Claus Larsen: Innovator in Pharmaceutical Chemistry

Introduction

Claus Larsen is a notable inventor based in Lejre, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on compounds that enhance the treatment of anaerobic infections. His expertise and dedication to research have led to the development of a unique patent that showcases his inventive capabilities.

Latest Patents

Claus Larsen holds a patent for the "Ester of metronidazole with N,N-dimethylglycine and acid addition salt." This patent describes the N,N-dimethylglycine ester of metronidazole, along with the acid addition salt thereof and the method of preparing such ester or acid addition salt. The novel compounds he developed exhibit favorable solubility in water, making them especially useful for the parenteral treatment of certain anaerobic infections.

Career Highlights

Claus Larsen is associated with A/S Dumex, a company that focuses on pharmaceutical innovations. His work at Dumex has allowed him to explore and develop new therapeutic solutions that address critical health challenges. His contributions have been instrumental in advancing the company's research initiatives.

Collaborations

Claus has collaborated with esteemed colleagues such as Pia Thorbek and Hans Bundgaard. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.

Conclusion

Claus Larsen's inventive spirit and dedication to pharmaceutical chemistry have led to significant advancements in the treatment of anaerobic infections. His patent reflects his commitment to improving healthcare through innovative solutions.